-
1
-
-
68749119666
-
Cationic liposomes as carriers for aerosolized formulations of an anionic drug: Safety and efficacy study
-
Bai S, Gupta V, Ahsan F. (2009). Cationic liposomes as carriers for aerosolized formulations of an anionic drug: safety and efficacy study. Eur J Pharm Sci 38: 165-71.
-
(2009)
Eur J Pharm Sci
, vol.38
, pp. 165-171
-
-
Bai, S.1
Gupta, V.2
Ahsan, F.3
-
2
-
-
65749090177
-
Risk of severe gastrointestinal events in women treated with monthly ibandronate or weekly alendronate and risedronate
-
Blumentals WA, Harris ST, Cole RE, et al. (2009). Risk of severe gastrointestinal events in women treated with monthly ibandronate or weekly alendronate and risedronate. Ann Pharmacother 43: 577-85.
-
(2009)
Ann Pharmacother
, vol.43
, pp. 577-585
-
-
Blumentals, W.A.1
Harris, S.T.2
Cole, R.E.3
-
3
-
-
0028954464
-
The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulizers
-
Clark AR. (1995). The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulizers. Int J Pharm 115: 69-78.
-
(1995)
Int J Pharm
, vol.115
, pp. 69-78
-
-
Clark, A.R.1
-
4
-
-
41849123834
-
Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: Time-dependent inhibition of human farnesyl pyrophosphate synthase
-
DOI 10.1021/jm7015733
-
Dunford JE, Kwaasi AA, Rogers MJ, et al. (2008). Structureactivity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase. J Med Chem 51: 2187-95. (Pubitemid 351503274)
-
(2008)
Journal of Medicinal Chemistry
, vol.51
, Issue.7
, pp. 2187-2195
-
-
Dunford, J.E.1
Kwaasi, A.A.2
Rogers, M.J.3
Barnett, B.L.4
Ebetino, F.H.5
Russell, R.G.G.6
Oppermann, U.7
Kavanagh, K.L.8
-
5
-
-
0035146537
-
Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates
-
Dunford JE, Thompson K, Coxon FP, et al. (2001). Structureactivity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resportion in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther 296: 235-42. (Pubitemid 32112446)
-
(2001)
Journal of Pharmacology and Experimental Therapeutics
, vol.296
, Issue.2
, pp. 235-242
-
-
Dunford, J.E.1
Thompson, K.2
Coxon, F.P.3
Luckman, S.P.4
Hahn, F.M.5
Poulter, C.D.6
Ebetino, F.H.7
Rogers, M.J.8
-
6
-
-
24644513398
-
Radiochemical and biological characteristics of radioactive iodine labeled indomethacin for imaging of inflammation
-
DOI 10.1007/s10967-005-0879-2
-
El-Ghany EA, Amine AM, EL-Sayed AS, et al. (2005). Radiochemical and biological characteristics of radioactive iodine labeled indomethacin for imaging of inflammation. J Radioanal Nucl Chem 266: 117-24. (Pubitemid 41285559)
-
(2005)
Journal of Radioanalytical and Nuclear Chemistry
, vol.266
, Issue.1
, pp. 117-124
-
-
El-Ghany, E.A.1
Amine, A.M.2
El-Sayed, A.S.3
El-Kolaly, M.T.4
Abdel-Gelil, F.5
-
7
-
-
0034739243
-
Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption
-
DOI 10.1016/S0169-409X(00)00061-2, PII S0169409X00000612
-
Ezra A, Golomb G. (2000). Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption. Adv Drug Deliv Rev 42: 175-95. (Pubitemid 30645777)
-
(2000)
Advanced Drug Delivery Reviews
, vol.42
, Issue.3
, pp. 175-195
-
-
Ezra, A.1
Golomb, G.2
-
8
-
-
77149157841
-
Generation of liposome aerosols with the aeroneb pro and the aeroprobe nebulizers
-
Gaspar MM, Gobbo O, Ehrhardt C. (2010). Generation of liposome aerosols with the Aeroneb Pro and the AeroProbe nebulizers. J Liposome Res 20: 55-61.
-
(2010)
J Liposome Res
, vol.20
, pp. 55-61
-
-
Gaspar, M.M.1
Gobbo, O.2
Ehrhardt, C.3
-
9
-
-
33846557959
-
Liposomes as an ocular delivery system for acetazolamide: In vitro and in vivo studies
-
Hathout RM, Mansour S, Mortada ND, Guinedi AS. (2007). Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS PharmSciTech 8:1.
-
(2007)
AAPS PharmSciTech
, vol.8
, pp. 1
-
-
Hathout, R.M.1
Mansour, S.2
Mortada, N.D.3
Guinedi, A.S.4
-
10
-
-
77953022632
-
Microemulsion formulations for the transdermal delivery of testosterone
-
Hathout RM, Woodman TJ, Mansour S, et al. (2010). Microemulsion formulations for the transdermal delivery of testosterone. Eur J Pharm Sci 40: 188-96.
-
(2010)
Eur J Pharm Sci
, vol.40
, pp. 188-196
-
-
Hathout, R.M.1
Woodman, T.J.2
Mansour, S.3
-
11
-
-
33644902058
-
Determination of risedronate in rat plasma samples by ion-pair high-performance liquid chromatography with uv detector
-
Jia HJ, Li W, Zhao K. (2006). Determination of risedronate in rat plasma samples by ion-pair high-performance liquid chromatography with UV detector. Analytica Chimica Acta 562: 171-5.
-
(2006)
Analytica Chimica Acta
, vol.562
, pp. 171-175
-
-
Jia, H.J.1
Li, W.2
Zhao, K.3
-
12
-
-
28244435462
-
Effect of physicochemical modification on the biodistribution and tumor accumulation of HPMA copolymers
-
DOI 10.1016/j.jconrel.2005.09.010, PII S0168365905004724
-
Lammers T, Kühnlein R, Kissel M, et al. (2005). Effect of physicochemical modification on the biodistribution and tumor accumulation of HPMA copolymers. J Contr Rel 110: 103-18. (Pubitemid 41713935)
-
(2005)
Journal of Controlled Release
, vol.110
, Issue.1
, pp. 103-118
-
-
Lammers, T.1
Kuhnlein, R.2
Kissel, M.3
Subr, V.4
Etrych, T.5
Pola, R.6
Pechar, M.7
Ulbrich, K.8
Storm, G.9
Huber, P.10
Peschke, P.11
-
13
-
-
54949109737
-
Pulmonary delivery of scutellarin solution and mucoadhesive particles in rats
-
Liu X-B, Ye J-X, Quan L-H, et al. (2008). Pulmonary delivery of scutellarin solution and mucoadhesive particles in rats. Eur J Pharm Biopharm 70: 845-52.
-
(2008)
Eur J Pharm Biopharm
, vol.70
, pp. 845-852
-
-
Liu, X.-B.1
Ye, J.-X.2
Quan, L.-H.3
-
16
-
-
19544376123
-
Optimizing the management of postmenopausal osteoporosis with bisphosphonates: The emerging role of intermittent therapy
-
DOI 10.1016/j.clinthera.2005.04.005, PII S0149291805000615
-
Miller PD. (2005). Optimizing the management of postmenopausal osteoporosis with bisphosphonates: the emerging role of intermittent therapy. Clin Ther 27: 361-76. (Pubitemid 40732645)
-
(2005)
Clinical Therapeutics
, vol.27
, Issue.4
, pp. 361-376
-
-
Miller, P.D.1
-
17
-
-
6444220920
-
Bisphosphonates and cancer
-
DOI 10.1892/0891-6640(2004)18<597:BAC>2.0.CO;2
-
Milner RJ, Farese J, Henry CJ, et al. (2004). Bisphosphonates and cancer. J Vet Intern Med 18: 597-604. (Pubitemid 39406859)
-
(2004)
Journal of Veterinary Internal Medicine
, vol.18
, Issue.5
, pp. 597-604
-
-
Milner, R.J.1
Farese, J.2
Henry, C.J.3
Selting, K.4
Fan, T.M.5
De Lorimier, L.-P.6
-
18
-
-
80053950940
-
Different modalities of nacl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting
-
Nasr M, Awad GAS, Mansour S, et al. (2011). Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting. Eur J Pharm Biopharm 79: 601-11.
-
(2011)
Eur J Pharm Biopharm
, vol.79
, pp. 601-611
-
-
Nasr, M.1
Awad, G.A.S.2
Mansour, S.3
-
19
-
-
84885668475
-
Hydrophilic versus hydrophobic porogens for engineering of poly(lactide-co-glycolide) microparticles containing risedronate sodium
-
Nasr M, Awad GAS, Mansour S, et al. (2013). Hydrophilic versus hydrophobic porogens for engineering of poly(lactide-co-glycolide) microparticles containing risedronate sodium. Pharm Dev Technol 18: 1078-88.
-
(2013)
Pharm Dev Technol
, vol.18
, pp. 1078-1088
-
-
Nasr, M.1
Awad, G.A.S.2
Mansour, S.3
-
20
-
-
54049121401
-
Vesicular aceclofenac systems: A comparative study between liposomes and niosomes
-
Nasr M, Mansour S, Mortada ND, Elshamy AA. (2008). Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. J Microencapsulation 25: 499-512.
-
(2008)
J Microencapsulation
, vol.25
, pp. 499-512
-
-
Nasr, M.1
Mansour, S.2
Mortada, N.D.3
Elshamy, A.A.4
-
21
-
-
84865293519
-
Amphotericin b lipid nanoemulsion aerosols for targeting peripheral respiratory airways via nebulization
-
Nasr M, Nawaz S, Elhissi A. (2012). Amphotericin B lipid nanoemulsion aerosols for targeting peripheral respiratory airways via nebulization. Int J Pharm 436: 611-16.
-
(2012)
Int J Pharm
, vol.436
, pp. 611-616
-
-
Nasr, M.1
Nawaz, S.2
Elhissi, A.3
-
23
-
-
0020466629
-
Cholesterol-phospholipid interaction in membranes. 1. Cholestane spin-label studies of phase behavior of cholesterol-phospholipid liposomes
-
DOI 10.1021/bi00259a016
-
Presti FT, Chan SI. (1982). Cholesterol-phospholipid interaction in membranes. 1. Cholestane spin-label studies of the phase behavior of cholesterol-phospholipid liposomes. Biochemistry 21: 3821-30. (Pubitemid 13230950)
-
(1982)
Biochemistry
, vol.21
, Issue.16
, pp. 3821-3830
-
-
Presti, F.T.1
Pace, R.J.2
Chan, S.I.3
-
24
-
-
0020401564
-
Cholesterol-phospholipid interaction in membranes. 2. Stoichiometry and molecular packing of cholesterol-rich domains
-
DOI 10.1021/bi00259a017
-
Presti FT, Pace RJ, Chan SI. (1982). Cholesterol-phospholipid interaction in membranes. 2. Stoichiometry and molecular packing of cholesterol-rich domains. Biochemistry 21: 3831-5. (Pubitemid 13230951)
-
(1982)
Biochemistry
, vol.21
, Issue.16
, pp. 3831-3835
-
-
Presti, F.T.1
Chan, S.I.2
-
25
-
-
33750845387
-
In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery
-
DOI 10.1016/j.addr.2006.07.012, PII S0169409X06001463
-
Sakagami M. (2006). In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv Drug Deliv Rev 58: 1030-60. (Pubitemid 44712023)
-
(2006)
Advanced Drug Delivery Reviews
, vol.58
, Issue.9-10
, pp. 1030-1060
-
-
Sakagami, M.1
-
26
-
-
84865282526
-
Design, optimization and in vitro evaluation of reverse-micelle loaded lipid nanocarriers containing erlotinib hydrochloride
-
Vrignaud S, Hureaux J, Wack S, et al. (2012). Design, optimization and in vitro evaluation of reverse-micelle loaded lipid nanocarriers containing erlotinib hydrochloride. Int J Pharm 436: 194-200.
-
(2012)
Int J Pharm
, vol.436
, pp. 194-200
-
-
Vrignaud, S.1
Hureaux, J.2
Wack, S.3
|